Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Philip I. Etebong"'
Publikováno v:
Data in Brief, Vol 36, Iss , Pp 107147- (2021)
This paper provides a control dataset of processed prognostic indicators for analysing drug resistance in patients on antiretroviral therapy (ART). The dataset was locally sourced from health facilities in Akwa Ibom State of Nigeria, West Africa and
Externí odkaz:
https://doaj.org/article/ede5bb70021e45a180f00a39fff78167
Autor:
Moses E. Ekpenyong, Mercy E. Edoho, Ifiok J. Udo, Philip I. Etebong, Nseobong P. Uto, Tenderwealth C. Jackson, Nkem M. Obiakor
Publikováno v:
Informatics in Medicine Unlocked, Vol 24, Iss , Pp 100568- (2021)
As we advance towards individualized therapy, the ‘one-size-fits-all’ regimen is gradually paving the way for adaptive techniques that address the complexities of failed treatments. Treatment failure is associated with factors such as poor drug a
Externí odkaz:
https://doaj.org/article/54cfe243ad7b454399507860b37412bf
Publikováno v:
Heliyon, Vol 5, Iss 7, Pp e02080- (2019)
Drug component interactions are most likely to trigger unexpected pharmacological effects with unknown causal mechanisms, hence, demanding the discovery of patterns to establish suitable and effective regimens. This paper proposes a novel framework t
Externí odkaz:
https://doaj.org/article/0e259671978f407fbc6ebce30570a6d9
Publikováno v:
Soft Computing. 24:17349-17364
Understanding pharmacology and drug resistance patterns plus appropriate use of laboratory testing is vital for managing treatment-experienced patients with new agents. While we acknowledge that patients with extensive drug resistance now have multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5d977f1575c740bcbf2811dd5f11fef
https://doi.org/10.1007/s00500-020-05024-1
https://doi.org/10.1007/s00500-020-05024-1
Autor:
Philip I. Etebong, Ifiok J. Udo, Tenderwealth Clement Jackson, Mercy E. Edoho, Nkem Mercy Obiakor, Moses Ekpenyong, Nseobong P. Uto
Publikováno v:
Informatics in Medicine Unlocked, Vol 24, Iss, Pp 100568-(2021)
Funding: This research is funded by the Tertiary Education Trust Fund (TETFund), Nigeria. As we advance towards individualized therapy, the ‘one-size-fits-all’ regimen is gradually paving the way for adaptive techniques that address the complexit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e54db4dc9dad635bb0778e9f2e0d531
https://hdl.handle.net/10023/23324
https://hdl.handle.net/10023/23324
Publikováno v:
Heliyon
Heliyon, Vol 5, Iss 7, Pp e02080-(2019)
Heliyon, Vol 5, Iss 7, Pp e02080-(2019)
Drug component interactions are most likely to trigger unexpected pharmacological effects with unknown causal mechanisms, hence, demanding the discovery of patterns to establish suitable and effective regimens. This paper proposes a novel framework t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a66541ad833dc76c6d561397dbb726e
http://europepmc.org/articles/PMC6656963
http://europepmc.org/articles/PMC6656963
Publikováno v:
Data in Brief
Data in Brief, Vol 36, Iss, Pp 107147-(2021)
Data in Brief, Vol 36, Iss, Pp 107147-(2021)
This paper provides a control dataset of processed prognostic indicators for analysing drug resistance in patients on antiretroviral therapy (ART). The dataset was locally sourced from health facilities in Akwa Ibom State of Nigeria, West Africa and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc78a8091ae5498e0b2a68cf99f5911
https://doi.org/10.1016/j.dib.2021.107147
https://doi.org/10.1016/j.dib.2021.107147